Awardee OrganizationCHILDREN'S HOSPITAL OF LOS ANGELES
Description
Abstract Text
(Adapted from the applicant's abstract) The goal of these studies is to
determine how the multilineage hematopoietic growth factor, granulocyte-
macrophage colony-stimulating factor (GM-CSF), stimulates the
proliferation and maturation of progenitor cells into specific myeloid
elements. Our studies will focus on a class of genes known to play an
important role in coordinating embryogenesis and differentiation in
Drosophila and Xenopus, the homeobox genes. These genes encode
transcription factors that contain a highly conserved 60-amino acid DNA-
binding motif known as the homeodomain. Homeobox genes can both
positively and negatively regulate the transcription of other genes, and
consequently, they play critical roles in anteriorposterior axis
formation, segmentation, and orchestrate the coordinated expression of
genes required to generate complex structures. The focus of this grant
application is to identify the homeobox genes that are involved in
myeloid differentiation and to elucidate how interaction of GM-CSF with
the myeloid progenitor cells affects the expression and action of these
homeobox genes.
Specific Aim 1 - Identify and characterize homeobox genes involved in
human myelopoiesis. Reverse transcription polymerase chain reaction
(RT-PCR), using degenerate primers recognizing the homeodomain, is
employed to identify the homeobox genes expressed in normal bone marrow
progenitors stimulated by GM- CSF, in semi-solid media, to undergo two
or three cell divisions. The expression of specific homeobox genes in
myeloid progenitors will be confirmed using quantitative RT-PCR (and
specific primers) of fluorescence-activated cell sorted (FACS) bone
marrow subsets. Evidence supporting a functional role for these
homeobox genes will be obtained using antisense oligonucleotides (ODN)
to block their expression in in vitro assays. We have successfully
employed these strategies to identify three HOX genes, and thus far, have
obtained biological data supporting the role of two of them in
myelopoiesis. Specific Aim 2 - Employ biological assays to determine the
functional role of specific homeobox genes in human myelopoiesis.
Retroviral vectors will be used to enforce expression of specific
homeobox genes in hematopoietic cell lines and primary hematopoietic
progenitor cells. Cell lines will be assayed for their responses to
multiple differentiation inducers. Transduced CD34+ progenitor cells
will be assayed in long-term culture assays for their differentiation
and proliferative potentials. Specific Aim 3 - Identify target genes
that are regulated by specific homeobox proteins during myelopoiesis.
Homeobox genes identified in Aim 1 and shown to play a physiologic role
in myelopoiesis in studies described in Aim 2 will be used to isolate
target genes. Inducible plasmid vectors directing the expression of a
specific HOX gene will be stably transfected into a model hematopoietic
cell line; "representational difference analysis" (RDA) will be used to
identify target genes that are either activated or repressed by the
expression of this homeobox gene.
No Sub Projects information available for 5P50HL054850-05 0001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50HL054850-05 0001
Patents
No Patents information available for 5P50HL054850-05 0001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50HL054850-05 0001
Clinical Studies
No Clinical Studies information available for 5P50HL054850-05 0001
News and More
Related News Releases
No news release information available for 5P50HL054850-05 0001
History
No Historical information available for 5P50HL054850-05 0001
Similar Projects
No Similar Projects information available for 5P50HL054850-05 0001